Volume 67, no. 10, p. 5361–5366. Page 5361, abstract, lines 12 and 13: “α3-fucosylation in H. pylori precedes α3-fucosyltransferase” should read “α3-fucosylation precedes α2-fucosylation.”
. 1999 Dec;67(12):6715.
Phase Variation in Helicobacter pylori Lipopolysaccharide due to Changes in the Lengths of Poly(C) Tracts in α3-Fucosyltransferase Genes
Ben J Appelmelk
1, Steve L Martin
1, Mario A Monteiro
1, Chris
A Clayton
1, Andrew A McColm
1, Pengyuan Zheng
1, Theo Verboom
1, Janneke J Maaskant
1, Dirk H van den Eijnden
1, Cornelis H Hokke
1, Malcolm B Perry
1, Christina M J E Vandenbroucke-Grauls
1, Johannes G Kusters
1
Ben J Appelmelk
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Ben J Appelmelk
Steve L Martin
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Steve L Martin
Mario A Monteiro
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Mario A Monteiro
Chris A Clayton
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Chris
A Clayton
Andrew A McColm
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Andrew A McColm
Pengyuan Zheng
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Pengyuan Zheng
Theo Verboom
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Theo Verboom
Janneke J Maaskant
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Janneke J Maaskant
Dirk H van den Eijnden
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Dirk H van den Eijnden
Cornelis H Hokke
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Cornelis H Hokke
Malcolm B Perry
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Malcolm B Perry
Christina M J E Vandenbroucke-Grauls
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Christina M J E Vandenbroucke-Grauls
Johannes G Kusters
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Find articles by Johannes G Kusters
1Departments of Medical Microbiology and Medical Chemistry, Vrije Universiteit, Medical School, 1081 BT Amsterdam, The Netherlands; Glaxo Wellcome Medicines Research Centre, Stevenage, United Kingdom; and Institute of Biological Sciences, National Research Council, Ottawa, Canada
Copyright © 1999, American Society for Microbiology
PMCID: PMC97091
This corrects the article "Phase Variation in Helicobacter pylori Lipopolysaccharide due to Changes in the Lengths of Poly(C) Tracts in α3-Fucosyltransferase Genes" on page 5361.